It not only effectively predicts decreased SHBG and elevated FAI—serving as an auxiliary tool for assessing hyperandrogenemia—but also shows an association with ovulatory dysfunction, although its specific applications require further validation in combination with other biomarkers. The gene discussed is SHBG; the disease is polycystic ovary syndrome.